ConductScience.org, home

Paper · 9727059

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18312226Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis.Int Immunol1993https://conductscience.org/library/papers/8312226PubMed
28274468ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.Arterioscler Thromb1994https://conductscience.org/library/papers/8274468PubMed
38020574Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice.Eur J Immunol1994https://conductscience.org/library/papers/8020574PubMed
47927412Pooled human IgG modulates cytokine production in lymphocytes and monocytes.Immunol Rev1994https://conductscience.org/library/papers/7927412PubMed
59169506IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.J Clin Invest1997https://conductscience.org/library/papers/9169506PubMed
63102491Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products.J Biol Chem1987https://conductscience.org/library/papers/3102491PubMed
77927415V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig).Immunol Rev1994https://conductscience.org/library/papers/7927415PubMed
87732003T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7732003PubMed
97667279Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7667279PubMed
107584501Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg).Ther Immunol1994https://conductscience.org/library/papers/7584501PubMed
118609246Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.J Clin Invest1996https://conductscience.org/library/papers/8609246PubMed
128633015Immunologic basis of transplant-associated arteriosclerosis.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8633015PubMed
138701976Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.Am J Pathol1996https://conductscience.org/library/papers/8701976PubMed
149114044T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9114044PubMed
152465552Low density lipoprotein undergoes oxidative modification in vivo.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2465552PubMed
162659887Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits.Lab Invest1989https://conductscience.org/library/papers/2659887PubMed
172794046Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.J Clin Invest1989https://conductscience.org/library/papers/2794046PubMed
182480105Complement receptors and regulatory proteins in human atherosclerotic lesions.Arteriosclerosis1989https://conductscience.org/library/papers/2480105PubMed
191693068Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.Arteriosclerosis1990https://conductscience.org/library/papers/1693068PubMed
202015703Beneficial effect of human therapeutic intravenous immunoglobulins (IVIg) in mercuric-chloride-induced autoimmune disease of Brown-Norway rats.Clin Exp Immunol1991https://conductscience.org/library/papers/2015703PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/9727059/references